Does liposomal bupivacaine reduce hospital length of stay for multilevel lumbar decompressions? A retrospective matched cohort study

Author:

Alhammoud Abduljabbar1,Bouloussa Houssam1,Oganesian Armen1,Moghamis Isam S2,Kuo Calvin1,Majid Kamran1,Bains Ravinder-Raj S.1

Affiliation:

1. Department of Regional Spine Surgery, Kaiser Permanente-Oakland Medical Center, Oakland, California, United States,

2. Department of Orthopedics Surgery, Hamad Medical Corporation, Doha, Qatar,

Abstract

Objectives: Adequate post-operative pain control improves patient outcomes, leading to fewer analgesia-related complications and shorter length of hospital stay (LOS). Liposomal bupivacaine (LB) is a long-acting injectable anesthetic. This study evaluates the impact of local LB use on pain control outcomes (LOS, visual analog scale [VAS], narcotic usage, readmission, and complications) after multilevel spinal decompression surgery compared to matched cohorts without local LB. Methods: A single-center retrospective cohort study matched by age, gender, body mass index (BMI), medical comorbidities, and previous use of opioids was done at our institute. Subjects were divided into two groups; one who had LB at the end of spine surgery and one without LB. Patients’ demographics, number of operating levels, and outcomes parameters (LOS and VAS), number of pain medications used preoperatively, through the hospitalization and at discharge, complication rate, and readmission rate were collected. Results: Eighty-six patients with spinal stenosis were included; 45 (52.3%) in the LB group and 41 (47.7%) in the non-LB group. The average age was 67.8 ± 10.5. Both groups were comparable in terms of BMI and medical comorbidities. There was no diffidence in pain killers consumption between the two groups, throughout hospitalization and at the discharge. Strong statistically significant difference with VAS score favoring LB use (P < 0.001). LOS was 15 h less in the LB group (32.4 ± 36.6 vs. 47.5 ± 39.1) (P = 0.069). The complication rate was 10.6%, with no difference between both groups (P = 0.49). Both groups had no readmissions or the emergency department visits for pain complaints. After excluding patients with complications, LOS was significantly shorter in the LB group (P = 0.029). In subgroup analysis for the LB group to look for the impact of the learning curve, the VAS score was less, and LOS was shorter in the second half of the included patients. However, the difference did not reach statistical significance. Conclusion: LB, as local infiltration at the end of a multilevel lumbar decompression, is an effective tool to decrease post-operative pain and shorten hospital stay, especially in patient with no post-operative complications.

Publisher

Scientific Scholar

Reference24 articles.

1. Liposomal bupivacaine and clinical outcomes;Tong;Best Pract Res Clin Anaesthesiol,2014

2. The efficacy of preemptive analgesia for acute postoperative pain management: A meta-analysis;Ong;Anesth Analg,2005

3. Enhanced recovery after surgery (ERAS) program for lumbar spine fusion;Smith;Perioper Med,2019

4. Bupivacaine liposomal injection (Exparel) for post surgical pain;Med Lett Drugs Ther,2012

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3